Cantabio Pharmaceuticals Inc.
company.status.inactiveCIK 1550518fmd_0J163HF0QJRYTVPQ651QT4WWS6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2012 to Dec 31, 2018, 27 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | – | – | – | – |
| Research and development | – | – | 0 | 0 | 0 | 0 |
| Total operating expenses | 0 | 0 | 0 | – | – | – |
| Operating income | (0) | (0) | – | – | – | – |
| Interest expense | – | – | – | – | 0 | 1 |
| Other non-operating income (expense) | – | – | 0 | 0 | (0) | (1) |
| Income tax expense | 0 | 0 | – | – | – | – |
| Net income from continuing operations | – | (0) | (0) | (1) | (1) | (1) |
| Net income | (0) | (0) | 0 | (1) | (1) | (2) |